World Orphan Drug Congress USA 2019
April 10, 2019 – April 12, 2019 • Gaylord National Harbor Hotel, Oxon Hill, MDRegistration
The Global Orphan Drug Conference & Expo
World Orphan Drug Congress USA will be bringing together 1,200+ leaders in rare disease research & orphan drug development from 50+ countries.
World Orphan Drug Congress USA will feature 350+ speakers across 9 categories including:
- Clinical Development
- Rare Disease Advocacy
- Global Market & Patient Access
- Pricing & Reimbursement
- Advanced Therapies- Clinical
- Advanced Therapies- Manufacturing
- Rare Oncology
- Pitch & Partner
For more information, click here to download the brochure >
Speakers are confirmed from Alnylam Pharmaceuticals, Pfizer Rare Disease, Loxo Oncology, Bluebird Bio, Sangamo Therapeutics, NORD, EURORDIS, FDA & ICER. Click here to see the full list of speakers >
Do not miss the chance to meet key decision makers from biopharma, biotechs, government, regulators & patient groups and more.